DNA Methyltransferases

DNMT inhibitors block the DNA methyltransferases that add methyl groups to cytosine residues in genomic DNA. DNA methyltransferase (DNMT) activity at cytosine-guanine (CpG) sites helps silence genes, transposable elements and imprinted loci. DNMT1 copies existing methylation patterns after replication, and its loss causes embryonic lethality in mice. DNMT3A and DNMT3B establish new patterns during development, a role shown in knockout mice in 1999. Cytidine analogs were linked to the inhibition of DNA methylation and to cell differentiation as early as 1980. The category includes the nucleoside analogs azacitidine, decitabine, zebularine and guadecitabine, together with the non-nucleoside inhibitor RG108.

Items 51-60 of 60

  • DNMT-IN-6
    Cat. No.
    A57710

    DNMT-IN-6

    DNMT-IN-6 is a potent DNA methyltransferase inhibitor targeting DNMT1, DNMT3A, and DNMT3B. It promotes demethylation and restores expression of the TMS1 tumor suppressor gene, leading to apoptosis and G2/M phase cell cycle arrest. Additionally, DNMT-IN-6 disrupts mitochondrial integrity and activates the intrinsic caspase cascade (caspases 3, 7, and 9). This compound demonstrates potential in inhibiting tumor growth and enhancing survival in xenograft models, making it a valuable tool for cancer research, particularly in the study of diffuse large B-cell lymphoma.

    Out of stock

    All 3 sizes
  • DNMT1-IN-3
    Cat. No.
    A57711

    DNMT1-IN-3

    DNMT1-IN-3 is a potent inhibitor of DNA methyltransferase 1 (DNMT1), exhibiting an IC50 of 0.777 μM and a KD of 0.183 μM. This compound selectively binds to the S-adenosyl-l-methionine (SAM) site on DNMT1, effectively disrupting its methylation activity. DNMT1-IN-3 demonstrates significant biological activity by inhibiting cell proliferation in K562 cells, primarily through the induction of apoptosis and cell cycle arrest in the G0/G1 phase. Its properties make it a valuable tool for research in hematologic tumors and epigenetic regulation.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • DNMT-IN-1
    Cat. No.
    A57715

    DNMT-IN-1

    DNMT-IN-1 is a potent inhibitor of DNA methyltransferases (DNMTs), exhibiting an EC50 value of 3.2 µM. This compound demonstrates significant antiproliferative activity, making it valuable for research applications involving epigenetic regulation and cancer biology. DNMT-IN-1 provides a useful tool for studying the role of DNA methylation in various diseases and therapeutic contexts.

    Out of stock

    All 3 sizes
  • 2′-Deoxy-5-nitrocytidine
    Cat. No.
    A57717

    2′-Deoxy-5-nitrocytidine

    2′-Deoxy-5-nitrocytidine is a potent inhibitor of DNA methyltransferase, disrupting the methylation process crucial for gene expression regulation. This compound is primarily utilized in cancer research to investigate its effects on tumorigenesis and cellular differentiation. By modulating DNA methylation patterns, it provides valuable insights into epigenetic modifications and their implications in various malignancies.

    Out of stock

    All 3 sizes
  • Hhal Methyltransferase
    Cat. No.
    A57718

    Hhal Methyltransferase

    Synonyms: Hhal

    HhaI Methyltransferase is a DNA methyltransferase that specifically recognizes the sequence GCGC. This enzyme catalyzes the transfer of a methyl group to cytosine residues within this recognition site, playing a critical role in the regulation of gene expression and genomic stability. It is widely utilized in epigenetic research, DNA methylation studies, and the development of methylation-sensitive tools for molecular biology applications.

    Out of stock

    All 3 sizes
  • MS9024
    Cat. No.
    A57719

    MS9024

    MS9024 is a selective degrader of DNA methyltransferase 1 (DNMT1), facilitating its degradation in HCT116 cells through the ubiquitin-proteasome pathway, achieving a DC50 of 35 nM. In additional cell lines, such as MDA-MB-468 and H1299, MS9024 shows DC50 values of 254 nM and 101 nM, respectively. Furthermore, it exhibits inhibitory activity against DNMT1 with an IC50 of 0.43 μM, making it a valuable tool for studying the role of DNMT1 in epigenetic regulation and its implications in cancer research.

    5 mg
    $215.00
    10 mg
    $355.00
    All 4 sizes
  • (Rac)-RG108
    Cat. No.
    A57722

    (Rac)-RG108

    Synonyms: (Rac)-N-Phthalyl-L-tryptophan

    (Rac)-RG108, a potent DNMT1 inhibitor, specifically targets DNA methyltransferases, playing a crucial role in epigenetic regulation. By blocking DNMT1 activity, it can modulate DNA methylation patterns, making it a valuable tool in epigenetic research. This compound is useful for studies investigating gene expression, cancer biology, and potential therapeutic strategies for diseases related to altered DNA methylation.

    5 mg
    $245.00
    10 mg
    $405.00
    All 2 sizes
  • DNMT1-IN-4
    Cat. No.
    A57723

    DNMT1-IN-4

    DNMT1-IN-4 is a potent non-nucleoside inhibitor of DNA methyltransferase 1 (DNMT1), exhibiting an IC50 value of 2.5 µM. This compound demonstrates selective inhibition of DNMT1 over other AdoMet-dependent protein methyltransferases. DNMT1-IN-4 effectively reduces cancer cell proliferation, making it a valuable tool for investigating the role of DNA methylation in cancer biology and epigenetic research.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • Hydralazine
    Cat. No.
    B21298

    Hydralazine

    Hydralazine is a potent DNA methyltransferase inhibitor that effectively crosses the blood-brain barrier. It reactivates silenced tumor suppressor genes through DNA demethylation, while also demonstrating vasodilatory effects and neuroprotective activities. Key biological effects include inhibition of NOS-2 (iNOS) and COX-2, leading to reduced nitric oxide and prostaglandin E2 production, as well as the scavenging of reactive oxygen species and suppression of macrophage activation. Hydralazine has applications in research related to hypertension, various cancers, spinal cord injury, and the mechanisms underlying inflammatory pain.

    5 mg
    $50.00
    10 mg
    $85.00
    All 5 sizes
  • SC83288
    Cat. No.
    B21936

    SC83288

    SC83288 is an inhibitor of PfDNMT2 in Plasmodium falciparum, with an IC50 of 7 μM. This compound disrupts the epigenetic regulation within malaria parasites, impeding DNA replication and nuclear division, and consequently arrests the development of the asexual blood stage. SC83288 also induces pyknotic morphology in the parasites without impacting cytokinesis post-nuclear division or parasite egress, making it valuable for malaria-related research applications.

    Out of stock

    All 3 sizes

Items 51-60 of 60

Added to your cart

View Cart Checkout

    Loading...